<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16785">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02102009</url>
  </required_header>
  <id_info>
    <org_study_id>OFOS-01-012</org_study_id>
    <nct_id>NCT02102009</nct_id>
  </id_info>
  <brief_title>Nutritional Supplementation in Adults With Chronic Respiratory Disease</brief_title>
  <acronym>OFOS</acronym>
  <official_title>Impact of Nutritional Support With an Complete Formula on Nutritional Status and Respiratory Function in Adult Patients Malnourished or at Risk of Malnutrition and Chronic Respiratory Disease..</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratorios Ordesa</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peruvian Clinical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Laboratorios Ordesa</source>
  <oversight_info>
    <authority>Peru: Instituto Nacional de Salud</authority>
    <authority>Peru: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether nutritional support with a complete
      formula  is effective to improve malnutrition and respiratory function in patients with
      chronic pulmonary disease compared to the standard hospital dietary advise.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a unicenter, controlled, randomized, prospective, parallel-group, open-label study
      to evaluate the effect of a nutritional formula on nutritional status, pulmonary function
      and quality of life. Adult patients will be randomized to receive the nutritional formula or
      to follow the standard hospital' dietetic recommendations during 12 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Changes in nutritional status</measure>
    <time_frame>At hospital discharge or at 1th month and at 3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Differences in weight, body mass index and fat free mass index evaluated by anthropometric measures.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in pulmonary function</measure>
    <time_frame>At 3rd month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Differences in forced expiratory volume measured by spirometry.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory Infections</measure>
    <time_frame>At 1st, 2nd, 3rd month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Differences measured by number of infections and hospital readmission rate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscular Strength</measure>
    <time_frame>At 3rd month.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Differences measured by hand-grip strength.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise Tolerance</measure>
    <time_frame>At 3th month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Differences measured by six minutes walk test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>At hospital discharge or 1st month and 3rd month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Differences measured by Saint George respiratory questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerability</measure>
    <time_frame>At 1st, 2nd and 3rd months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by gastrointestinal discomfort and product compliance.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Malnutrition</condition>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <condition>Other Pulmonary Disease, Chronic Obstructive</condition>
  <arm_group>
    <arm_group_label>Vitafos</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Complete enteral formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary Advise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary advise according to the hospital routine clinical practice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Complete enteral formula</intervention_name>
    <description>Product: Complete nutritional formula in powder enriched with key nutrients to be administered orally (200 ml of water per 57 g product).
Time of intervention: 3 months.</description>
    <arm_group_label>Vitafos</arm_group_label>
    <other_name>Vitafos</other_name>
    <other_name>Vitafos Adultos</other_name>
    <other_name>Vitafos Vainilla</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Advise</intervention_name>
    <description>Patients will receive the usual dietary advise in these patients according  hospital clinical practice .</description>
    <arm_group_label>Dietary Advise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged between 18 and 80 years.

          -  Patient from Clínica San Gabriel or Clínica San Pablo Surco, inpatient or outpatient.

          -  Patients with chronic pulmonary disease (including bronchiectasis, tuberculosis
             specific sequel, fibrothorax, diffuse interstitial lung disease, COPD).

          -  Patients presenting one or more of the following situations of malnutrition or
             nutritional risk: BMI &lt;21 kg/m2 (or&lt;23 kg/m2 in patients ≥ 65); unintentional weight
             loss &gt;10% in the past 6 months; unintentional weight loss &gt;5% in last moth; FFMI  &lt;15
             kg/m2 (women) or &lt;16 kg/m2 (men).

          -  Patients who signed informed consent.

        Exclusion Criteria:

          -  Clinically unstable patients.

          -  Patients requiring other nutritional supplements or parenteral nutrition.

          -  Patients diagnosed with active pulmonary tuberculosis.

          -  Patients with acute respiratory failure.

          -  Patients with immunosuppression (including HIV, diabetes or neoplasms).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Antonio Camere Torrealva, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clínica San Gabriel - Perú</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marco Antonio Camere Torrealva, Doctor</last_name>
    <email>marco_camere@sanpablo.com.pe</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clínica San Gabriel</name>
      <address>
        <city>San Miguel</city>
        <state>Lima</state>
        <zip>2955</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marco Antonio Camere Torrealva, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Peru</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 28, 2014</lastchanged_date>
  <firstreceived_date>March 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Malnutrition</keyword>
  <keyword>Dietary supplement</keyword>
  <keyword>Nutritional supplement</keyword>
  <keyword>Complete enteral formula</keyword>
  <keyword>COPD</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
